Legacy Capital Group California, Inc.

Position in ROIV — Roivant Sciences Ltd.

CIK 1977092 LOS GATOS, CA

Position in ROIV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$672,374

+$213,856 QoQ

Shares Held

18,999

+14.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#258

of 494 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 4% Shared 0% None 96%

Healthcare · as of Jun 30, 2026

Legacy Capital Group California, Inc. holds $5,964,018 across 4 Biotechnology names. ROIV ranks #3 (11.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IBRX	ImmunityBio, Inc.	446,000	$3,904,730
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,118	$1,052,074
3	ROIV	Roivant Sciences Ltd. This page	18,999	$672,374
4	REGN	Regeneron Pharmaceuticals, Inc.	537	$334,840

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$672,374	18,999	+14.8%	Shares	Sole	2026-07-29
2026-03-31	$458,518	16,553	-21.8%	Shares	Sole	2026-05-04
2025-12-31	$459,215	21,162	—	Shares	Sole	2026-01-28
No filing history on record for this holder in this stock.